Global Propofol Drug Market Growth 2025-2031

Global Propofol Drug Market Growth 2025-2031

The global Propofol Drug market size is predicted to grow from US$ 1370 million in 2025 to US$ 1684 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.

Propofol drug is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting.

The largest manufacturer of Propofol Drug in the U.S. region is Fresenius Kabi, which holds about 71% share. In terms of product type, 20 mL is the largest segment, accounting for a share of 55%. In terms of application, General Anesthesia is the largest field with a share about 64 percent.

LP Information, Inc. (LPI) ' newest research report, the “Propofol Drug Industry Forecast” looks at past sales and reviews total world Propofol Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Propofol Drug sales for 2025 through 2031. With Propofol Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol Drug industry.

This Insight Report provides a comprehensive analysis of the global Propofol Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Propofol Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Propofol Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
10 mL
20 mL
50 mL
100 mL

Segmentation by Application:
General Anesthesia
Medical Procedures Sedation
Mechanical Ventilation
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Fresenius Kabi
Aspen Pharma
B. Braun
Pfizer
Dr. Reddy's Laboratories
Rusoma
Centurion Healthcare
Wellona Pharma
NEON
Flagship Biotech
Xi’an Libang Pharmaceutical
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Sichuan Kelun Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Jiangsu Yingke Biopharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Propofol Drug market?

What factors are driving Propofol Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Propofol Drug market opportunities vary by end market size?

How does Propofol Drug break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.